Acriptega
A Tenofovir/Lamivudine/Dolutegravir brand by Aurobindo Pharma — tablet, made in India.
NAFDAC registration
Our July 2026 copy of the NAFDAC Greenbook records the listing Acriptega Tablets (B4-9927) with status “Expired”. Listings can lag renewals — confirm the current status on the official Greenbook before buying.
Acriptega at a glance
- Generic name
- Tenofovir/Lamivudine/Dolutegravir
- Manufacturer
- Aurobindo Pharma
- Form
- Tablet
- Strength
- Tenofovir 300mg/Lamivudine 300mg/Dolutegravir 50mg
- Made in
- India
- NAFDAC reg. no.
- B4-9927
Acriptega price in Nigeria
Tenofovir/Lamivudine/Dolutegravir products typically cost ₦500 - ₦5,000 per pack in Nigerian pharmacies.
Figures cover Tenofovir/Lamivudine/Dolutegravir products across brands and pack sizes, sampled from licensed Nigerian online pharmacies — indicative only. Track month-by-month movement on the Medicine Price Index.
About Tenofovir/Lamivudine/Dolutegravir
Tenofovir/Lamivudine/Dolutegravir, commonly known as TLD, is a fixed-dose combination antiretroviral tablet used for the treatment of HIV-1 infection. It combines three powerful antiretroviral medicines into a single pill: Tenofovir disoproxil fumarate (300mg), an NRTI that blocks the HIV reverse transcriptase enzyme; Lamivudine (300mg), another NRTI that works similarly to tenofovir but targets a different step in viral replication; and Dolutegravir (50mg), an integrase strand transfer inhibitor (INSTI) that prevents HIV from inserting its genetic material into human cells. Nigeria has the second largest HIV burden in the world, with approximately 1.9 million people living with HIV, and TLD has become the cornerstone of the national antiretroviral therapy programme. The shift to TLD represents a major advance in HIV treatment in Nigeria, offering superior viral suppression with fewer side effects compared to older regimens.
Read the full Tenofovir/Lamivudine/Dolutegravir guide — dosage, side effects, warnings, and all registered brands.
Frequently asked questions
Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: July 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated July 2026.